blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2426111

EP2426111 - 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.02.2013
Database last updated on 25.09.2024
Most recent event   Tooltip01.02.2013Application deemed to be withdrawnpublished on 06.03.2013  [2013/10]
Applicant(s)For all designated states
Laboratorios del Dr. Esteve, S.A.
Avda. Mare de Déu de Montserrat, 221
08041 Barcelona / ES
[N/P]
Former [2012/10]For all designated states
Laboratorios del. Dr. Esteve, S.A.
Avda. Mare de Déu de Montserrat 221
08041 Barcelona / ES
Inventor(s)01 / Benet Buchholz, Jordi
Plaza Romani 3
Casa A
E-43893 Altafulla - (Tarragona) / ES
02 / Puig Fernandez, Laura
C/ El maquinista de la General, 37 2A
E-50019 Zaragoza / ES
 [2012/16]
Representative(s)ABG Intellectual Property Law, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
[N/P]
Former [2012/10]ABG Patentes, S.L.
Avenida de Burgos 16D Edificio Euromor
28036 Madrid / ES
Application number, filing date10382225.009.08.2010
[2012/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2426111
Date:07.03.2012
Language:EN
[2012/10]
Search report(s)(Supplementary) European search report - dispatched on:EP12.01.2011
ClassificationIPC:C07D231/22, A61P25/16, A61P25/00, A61K31/4152
[2012/10]
CPC:
C07D231/22 (EP,US); C07D413/12 (KR); A61K31/5377 (KR);
A61P25/00 (EP); A61P25/04 (EP); A61P25/16 (EP);
A61P43/00 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/10]
Extension statesBANot yet paid
MENot yet paid
RSNot yet paid
TitleGerman:Feste 4-[-2-[[5-Methyl-1-(2-naphthalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholinhydrochlorid-Formen[2012/10]
English:4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms[2012/10]
French:Formes cristallines de chlorhydrate de 4-[-2-[[5-méthyl-1-(2-naphtalényl)-1h-pyrazol-3-yl]oxy]éthyl]morpholine[2012/10]
Examination procedure08.09.2012Application deemed to be withdrawn, date of legal effect  [2013/10]
19.10.2012Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2013/10]
Fees paidPenalty fee
Additional fee for renewal fee
31.08.201203   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]US2008125416  (LAGGNER CHRISTIAN [AT], et al) [AD] 1-10 * example 61 *;
 WO2006021462  [ ] (ESTEVE LABOR DR [ES], et al);
 [A]EP2116539  (ESTEVE LABOR DR [ES]) [A] 1-10 * the whole document *
by applicantWO2006021462
 WO9741114
    - WALKER, J.M. ET AL., PHARMACOLOGICAL REVIEWS, (1990), vol. 42, page 355
    - SNYDER, S.H.; LARGENT, B.L., J. NEUROPSYCHIATRY, (1989), vol. 1, page 7
    - QUIRION, R. ET AL., TRENDS PHARMACOL. SCI., (1992), vol. 13, pages 85 - 86
    - HANNER, M. ET AL., PROC. NATL. ACAD. SCI., (1996), vol. 93, pages 8072 - 8077
    - M. LANG ET AL., J. AM. CHEM. SOC., (2002), vol. 124, page 14834
    - C. PRICE ET AL., J. AM. CHEM. SOC., (2005), vol. 127, page 5512
 EP20100382025
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.